Track Cassava Sciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Cassava Sciences, Inc. SAVA · Stock Open Cassava Sciences, Inc. in new tab

1.32 USD
EPS
-2.22
P/B
1.41
ROE
-85.44
Beta
-0.84
Loading chart...
Key Metrics
EPS-2.22
Book Value1.69
Price to Book1.41
% Insiders12.787%
Estimates
Forward P/E-1.34
Forward EPS-1.77

DCF valuation

Model fair value for Cassava Sciences, Inc. (SAVA)
Result
Sign in to run the valuation for SAVA.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Cassava Sciences, Inc. Logo Cassava Sciences, Inc. Analysis (SAVA)

United States Health Care Official Website Stock

Is Cassava Sciences, Inc. a good investment? Cassava Sciences, Inc. (SAVA) is currently trading at 1.32 USD.

Investor FAQ

Does Cassava Sciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Cassava Sciences, Inc.?

Cassava Sciences, Inc. is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

Company Profile

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.

Exchange Ticker
NMS (United States) SAVA
MEX (Mexico) SAVA.MX
NASDAQ FLNA
FRA (Germany) PX91.F
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2012
0.75 USD
Dec. 24, 2012 0.7500
▸2010
2.00 USD
Dec. 13, 2010 2.0000
Stock Splits
Split Date Split Ratio to 1
May 10, 2017 1:7
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion